China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.290
+0.710 (44.94%)
At close: Apr 25, 2025, 4:00 PM
2.210
-0.080 (-3.49%)
Pre-market: Apr 28, 2025, 6:41 AM EDT

China SXT Pharmaceuticals Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2016 - 2019
Revenue
1.821.931.972.64.785.16
Upgrade
Revenue Growth (YoY)
6.78%-2.19%-24.23%-45.53%-7.45%-26.38%
Upgrade
Cost of Revenue
1.421.371.551.351.942.46
Upgrade
Gross Profit
0.40.550.431.252.842.7
Upgrade
Selling, General & Admin
-6.222.655.686.445.044.04
Upgrade
Operating Expenses
-6.222.655.686.445.044.04
Upgrade
Operating Income
6.62-2.09-5.26-5.19-2.2-1.34
Upgrade
Interest Expense
-0.4-0.55-0.48-0.04-1.12-3.35
Upgrade
Interest & Investment Income
0.010.01-00.01-
Upgrade
Other Non Operating Income (Expenses)
-0.01-0.040.15-0.180.36-0.07
Upgrade
EBT Excluding Unusual Items
6.22-2.68-5.59-5.41-2.94-4.76
Upgrade
Asset Writedown
-0.42-0.42-0.35---
Upgrade
Other Unusual Items
------5.63
Upgrade
Pretax Income
5.8-3.1-5.93-5.41-2.94-10.39
Upgrade
Income Tax Expense
---0.33-0.19-0.1
Upgrade
Net Income
5.8-3.1-5.93-5.74-2.75-10.29
Upgrade
Net Income to Common
5.8-3.1-5.93-5.74-2.75-10.29
Upgrade
Shares Outstanding (Basic)
000---
Upgrade
Shares Outstanding (Diluted)
000---
Upgrade
Shares Change (YoY)
378.48%224.91%----
Upgrade
EPS (Basic)
20.77-28.58-177.84---
Upgrade
EPS (Diluted)
20.77-28.58-177.84---
Upgrade
Free Cash Flow
-2.71-1.94-0.150.21-1.410.53
Upgrade
Free Cash Flow Per Share
-9.72-17.85-4.54---
Upgrade
Gross Margin
22.02%28.73%21.62%48.10%59.44%52.37%
Upgrade
Operating Margin
363.97%-108.49%-266.68%-199.43%-45.99%-25.98%
Upgrade
Profit Margin
318.69%-160.67%-301.00%-220.43%-57.52%-199.29%
Upgrade
Free Cash Flow Margin
-149.18%-100.34%-7.68%7.91%-29.50%10.22%
Upgrade
EBITDA
6.79-1.89-5.01-4.87-1.85-1.01
Upgrade
EBITDA Margin
373.27%-97.95%-253.99%-187.13%-38.76%-19.55%
Upgrade
D&A For EBITDA
0.170.20.250.320.350.33
Upgrade
EBIT
6.62-2.09-5.26-5.19-2.2-1.34
Upgrade
EBIT Margin
363.97%-108.49%-266.68%-199.43%-45.99%-25.98%
Upgrade
Revenue as Reported
1.821.931.972.64.785.16
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q